Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- Check6 days agoChange DetectedThe UP-NEXT study record is displayed with its clinical trial details, including the investigational treatment, participant criteria, study locations, and measured outcomes. The record identifies the study as terminated by the sponsor and no longer recruiting.SummaryDifference63%

- Check13 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA sitewide NIH banner announces an update about terminology used during the agency’s website transition. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study record details, replacing content with a generic error layout and a Home button. This indicates an access restriction rather than an update to the trial information.SummaryDifference18%

- Check62 days agoChange DetectedThe page shows a new revision tag v3.7.0, replacing the previous v3.6.6. This reflects a behind-the-scenes update without changes to the study details presented on the page.SummaryDifference0.0%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.